Products

FaceHeart Vitals Software Development Kit (FH vitals SDK)
FaceHeart
Developer Tools & APIs
FaceHeart Vitals SDK is an FDA-cleared, AI-driven software development kit enabling contactless measurement of vital signs like heart rate, blood pressure, and oxygen saturation via a standard camera, ideal for remote patient monitoring and telehealth.

See all 1 product →

About FaceHeart

FaceHeart is an AI-driven health technology company that specializes in contactless vital signs monitoring. Their flagship product, FaceHeart Vitals™, is an FDA-cleared software solution that utilizes a standard camera (e.g., on a smartphone, laptop, or smart TV) to measure key physiological parameters by analyzing subtle facial color variations. This technology allows for the remote and non-invasive assessment of vital signs such as heart rate, respiration rate, blood pressure, oxygen saturation (SpO2), heart rate variability (HRV), and stress index, typically within 40-60 seconds.

For physicians, FaceHeart Vitals™ offers a valuable tool for enhancing remote patient monitoring, telemedicine, and digital health initiatives. The software’s ability to integrate seamlessly into various devices and platforms via an SDK facilitates accessible health data collection, particularly beneficial for chronic disease management, elderly care, and home-based care. FaceHeart has obtained FDA 510(k) clearance as a Class II Software as Medical Device (SaMD) for heart rate and respiration rate, demonstrating its medical-grade accuracy and reliability. The company is also exploring advanced applications such as detecting atrial fibrillation (AFib) and supporting psychological assessments.

What Physicians Need to Know

Specialization
FaceHeart specializes in AI-driven, video-based contactless vital sign measurement. Their core product, FaceHeart Vitalsu2122, uses a standard camera to measure heart rate, blood pressure, respiration rate, oxygen saturation (SpO2), heart rate variability (HRV), and stress index. They are also developing capabilities for HBA1C, Hemoglobin, Cholesterol, and Atrial Fibrillation detection.
Key Differentiators
FaceHeart's primary differentiator is its contactless and non-invasive approach, utilizing standard device cameras (smartphones, tablets, laptops) for vital sign measurement, eliminating the need for wearables or physical contact. It is the first video-based vital sign solution to receive FDA 510(k) clearance as a Class II Software as a Medical Device (SaMD) for heart rate and respiration rate. The technology is backed by extensive clinical trials and millions of datasets, ensuring medical-grade accuracy. Its software-only SDK allows for seamless integration into existing platforms and edge devices, with processing done locally via edge computing to ensure data privacy and reduce latency.
Technology Stack
The core of FaceHeart's technology is Remote Photoplethysmography (rPPG), which extracts subtle color changes in facial tissue captured by a camera to determine physiological signals. This is powered by a multi-context deep learning framework, including deep learning CNN models and AI image recognition technology. Their solution is delivered via the FaceHeart Vitalsu2122 SDK, compatible with various edge devices such as iOS/Android smartphones, tablets, Windows laptops/desktops, smart home devices, and embedded system boards.
Physician Tip

For physicians, FaceHeart offers a powerful tool to enhance remote patient monitoring and telemedicine. The ability to obtain real-time, medical-grade vital signs (FDA-cleared for HR and RR) through a simple facial scan on common devices can significantly streamline virtual consultations and chronic disease management. This reduces the need for in-person visits and specialized equipment, making healthcare more accessible and cost-effective. The AI-assisted analysis can provide objective data for clinical decision-making, track health trends, and potentially aid in early detection of conditions, complementing existing diagnostic methods. Emphasize its non-invasive nature for improved patient comfort and compliance.

FaceHeart's FH Vitals SDK is designed for flexible and seamless integration into a wide range of existing software platforms and edge devices. This 'plug-and-play' capability means it can be easily incorporated into current telemedicine platforms, remote patient monitoring systems, and digital health applications without requiring additional specialized hardware, leveraging devices patients already own.

Products by FaceHeart

1 product in the directory

FaceHeart Vitals Software Development Kit (FH vitals SDK)
FaceHeart
Developer Tools & APIs
FaceHeart Vitals SDK is an FDA-cleared, AI-driven software development kit enabling contactless measurement of vital signs like heart rate, blood pressure, and oxygen saturation via a standard camera, ideal for remote patient monitoring and telehealth.

What the Web Says

FaceHeart is a company specializing in AI-powered, contactless vital sign measurement through facial video analysis. Their products, like the FaceHeart Vitals AI software and the FaceHeart CardioMirror, aim to make health monitoring accessible and convenient, particularly for remote patient monitoring and home healthcare. The technology has received FDA clearance for heart rate measurement, and the company is actively pursuing further medical certifications and expanding its product capabilities.

Overall: Positive

Strengths

  • Contactless vital sign measurement using a smartphone or webcam.
  • FDA clearance for heart rate measurement with FaceHeart Vitals AI software.
  • Measures multiple vital signs including heart rate, blood pressure, oxygen saturation, and respiration rate.
  • Potential for early detection of conditions like Atrial Fibrillation (AFib) and Heart Failure (HF) with high accuracy.
  • User-friendly interface and app for tracking health trends and personalized insights.
  • Enhances accessibility to healthcare, especially in underserved areas and for remote monitoring.

Limitations

  • Limited information available on employer reviews from major platforms like Glassdoor or Capterra.
  • Some Reddit discussions about similar technologies raise questions about accuracy and medical validation, though FaceHeart has FDA clearance for heart rate.
  • Accuracy for some vital signs (e.g., blood pressure) is still undergoing further FDA review and improvement.
  • Cost of the CardioMirror might be a barrier for some consumers.

Based on reviews from: FaceHeart Official Website / App Review, Notebookcheck, TrendHunter, Reddit (r/STEW_ScTecEngWorld), LinkCentre, Bioworld, YouTube (Medica 2024 Interview), Reddit (r/biotech), Reddit (r/Biohackers), Reddit (r/HealthTech)

Last updated: 2026-07-20

Videos

News, demos, and interviews about FaceHeart.

Loading videos...

Videos load interactively. If none appear, search YouTube for FaceHeart →

View all on YouTube

Press & Coverage

FaceHeart
FaceHeart Received Another FDA Clearance for its Contactless Video-Based Vital Sign Measurement of Respiratory Rate
FaceHeart Corporation received its second FDA 510(k) clearance for FaceHeart Vitalsu2122, a contactless video-based vital sign solution, specifically for respiratory rate measurement with deviations consistently within u00b12 breaths per minute. This follows their 2023 FDA clearance for heart rate measurement, solidifying their commitment to accessible and reliable contactless vital sign measurement.
2025-04
FaceHeart
FaceHeart has been selected for inclusion on the Forbes Asia 100 to Watch 2025 list
FaceHeart was selected for the Forbes Asia 100 to Watch 2025 list, recognizing its AI-powered contactless vital sign measurement solution, FaceHeart Vitalsu2122. This highlights the company's significant role in contactless well-being improvements and its commitment to driving innovation in smart healthcare systems.
2026-04
FaceHeart
FaceHeart Wins u201cBest Biometric Sensor Solutionu201d Designation in 2025 MedTech Breakthrough Awards Program
FaceHeart was honored with the u201cBest Biometric Sensor Solutionu201d designation in the 2025 MedTech Breakthrough Awards Program. This award further acknowledges FaceHeart's innovative contributions to the medical technology industry.
2025-05
Institute for Biotechnology and Medicine Industry (IBMI)
Mirrors Know Your Heart Rate: A Healthcare Breakthrough
FaceHeart's AI-based software, FaceHeart Vitalsu2122, received FDA approval in 2023 for measuring heart rate through video imagery, making it the first globally. The company also received an Innovation Award at CES for the second time and was selected for Forbes Asia 100 To Watch 2025.
2025-09
FaceHeart
FaceHeart has Obtained FDA 510(k) Clearance for its Video-Based Contactless Vital Sign Measurement
FaceHeart announced it received FDA 510(k) clearance for FaceHeart Vitalsu2122, its video-based contactless vital sign solution, as the first FDA-Cleared Class II SaMD for heart rate measurement in the market. This technology allows for the measurement of vital signs like heart rate, blood pressure, oxygen saturation, and respiration rate through a 50-second video recording.
2023-10
Yesil Science
Taiwanese Company FaceHeart Receives FDA Approval for AI-Based Respiratory Rate Measurement
FaceHeart, a Taiwanese technology firm, secured FDA 510(k) clearance for its AI-powered, contactless method of measuring respiratory rates, marking its second FDA approval. The SDK utilizes a smartphone camera to capture vital signs, including heart rate, respiratory rate, blood pressure, oxygen saturation, and heart rate variability in under 50 seconds.
2025-05
Healthcare+ B2B
FaceHeart Corp. nets $200 million in Series A from Taiwan Capital
FaceHeart completed a Series A funding round of $210 million, led by Taiwan Capital, with additional investors including Mega International Commercial Bank, Abico Group, and Shanghai Commercial and Savings Bank. The funding will support the development of FaceHeart Vitals solutions for various platforms and contexts globally.
2022-10
FaceHeart
Patient Monitoring and SaMD in Action: A Guide to New Biomedical Devices
FaceHeart Vitalsu2122 is the first AI-based medical software globally to be granted FDA Class II SaMD clearance for heart rate and respiratory rate monitoring using only a standard camera. The solution has been clinically validated on over 6,000 participants, accumulating over 300 million physiological data points.
2025-06

Frequently Asked Questions

FaceHeart primarily offers FaceHeart Vitalsu2122, an AI-driven, video-based contactless vital sign measurement solution. It is FDA-cleared for heart rate and respiration rate, and can also measure blood pressure, oxygen saturation, heart rate variability, stress index, and detect Atrial Fibrillation (AFib) through a 50-second facial scan.
FaceHeart Vitalsu2122 has received FDA 510(k) clearance as a Class II Software as a Medical Device (SaMD) for both heart rate (k223622) and respiratory rate (k243966) measurements. The company has conducted numerous clinical trials with top hospitals in Taiwan and the US, collecting over 300 million datasets from more than 6,000 testers to ensure accuracy.
FaceHeart emphasizes that it does not store any user data, including images or basic health information, from its web demo or official SDK package. The solution leverages edge computing, allowing AI-driven algorithms to run directly on devices without requiring cloud services, thereby enhancing data privacy and eliminating network latency.
FaceHeart offers a flexible business model, including a revenue share of 10-15% or a per-scan fee ranging from $0.10 to $0.15, depending on the implementation. For support, FaceHeart actively seeks distributors to provide local market understanding and customer assistance, and inquiries can be directed to their marketing email.
Yes, FaceHeart Vitalsu2122 is delivered as a Software Development Kit (SDK) designed for seamless integration into various smart devices and existing applications, including telemedicine platforms. Notable partnerships include Grupo Red Salud for their 'Salud Selfie' app and Emagine Solutions Technology for 'The Journey Pregnancy' app, enabling remote vital sign monitoring.
Founded in 2018, FaceHeart is a Series A company that has raised over $200 million in funding from investors including Taiwan Capital, Mega International Commercial Bank, Abico Group, and Shanghai Commercial and Savings Bank. The company has received industry recognition, such as being named a winner in the MedTech Breakthrough Awards program 2025 and included on the Forbes Asia 100 to Watch 2025 list.

Related Companies

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]

allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.